Inventor · disambiguated record
Peter Johannes Holst
Also filed as: HOLST PETER · HOLST PETER JOHANNES
8 granted patents·11 pending applications·12 citations·filing 2006–2025
79Inventor score
Files withINPROTHER APS6UNIV COPENHAGEN6COPENHAGEN UNIVERSITY2COPENHAGEN UNIV1GLAXOSMITHKLINE BIOLOGICALS SA1
Top patents by PatentIndex Score
19 records- 0193US11351247B2Vaccine for use in the prophylaxis and/or treatment of a diseaseINPROTHER APS·Filed 2018·Granted Jun 7, 2022·12 cites·21 claims
- 0286US12263214B2Vaccine for use in the prophylaxis and/or treatment of a diseaseINPROTHER APS·Filed 2024·Granted Apr 1, 2025·0 cites·13 claims
- 0380US12023377B2Vaccine for use in the prophylaxis and/or treatment of a diseaseINPROTHER APS·Filed 2022·Granted Jul 2, 2024·0 cites·16 claims
- 0480US11883487B2Vaccine for use in the prophylaxis and/or treatment of a diseaseINPROTHER APS·Filed 2022·Granted Jan 30, 2024·0 cites·20 claims
- 0576US2025186579A1Vaccine for use in the prophylaxis and/or treatment of a diseaseINPROTHER APS·Filed 2025·Application pending·0 cites
- 0674US12390522B2Nucleic acids encoding human endogenous retrovirus K (HERV-k) envelope proteins containing modified immunosuppressive domains (ISD) and uses thereofINPROTHER APS·Filed 2019·Granted Aug 19, 2025·0 cites·15 claims
- 0772US2011293704A1Priming of an immune responseHOLST PETER JOHANNES·Filed 2009·Application pending·0 cites
- 0869US2021386842A1Priming of an immune responseUNIV COPENHAGEN·Filed 2021·Application pending·0 cites
- 0968US2015056227A1Priming of an immune responseUNIV COPENHAGEN·Filed 2014·Application pending·0 cites
- 1062US11813327B2Ii vaccine adjuvantUNIV COPENHAGEN·Filed 2021·Granted Nov 14, 2023·0 cites·15 claims
- 1162US2021230633A1Nucleotide vaccineCOPENHAGEN UNIV·Filed 2021·Application pending·0 cites
- 1262US2017290898A1Priming of an immune responseUNIV COPENHAGEN·Filed 2017·Application pending·0 cites
- 1360US2025066427A1Therapeutic papilloma virus vaccinesSIRION BIOTECH GMBH·Filed 2022·Application pending·0 cites
- 1455US11179461B2Ii vaccine adjuvantUNIV COPENHAGEN·Filed 2018·Granted Nov 23, 2021·0 cites·15 claims
- 1552US2010278904A1Nucleotide vaccineCOPENHAGEN UNIVERSITY·Filed 2006·Application pending·0 cites
- 1646US2021030838A1Chemotaxis-potentiating peptides and uses thereofUNIV COPENHAGEN·Filed 2018·Application pending·0 cites
- 1745US2022202901A1Peptides in combination with immune checkpoint inhibitors for use in treatment of cancerWNTRESEARCH AB·Filed 2020·Application pending·0 cites
- 1843US2015368672A1Nucleotide vaccineCOPENHAGEN UNIVERSITY·Filed 2015·Application pending·0 cites
- 1935US11498956B2Fusion peptides with antigens linked to short fragments of invariant chain(CD74)GLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Granted Nov 15, 2022·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Peter Johannes Holst files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →